HETEROCYCLYLAMINO-SUBSTITUTED TRIAZOLES AS MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE
申请人:Redx Pharma Plc
公开号:EP4026834A1
公开(公告)日:2022-07-13
This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.
本发明涉及新型化合物和药物组合物,其中包括本发明化合物可作为Rho相关蛋白激酶(ROCK)的调节剂,例如ROCK1和/或ROCK2抑制剂。本发明还考虑了采用本发明化合物的治疗方法。本发明的化合物可用于治疗 ROCK 介导的疾病。
765. The structure and reactivity of pyridazine quaternary salts
作者:G. F. Duffin、J. D. Kendall
DOI:10.1039/jr9590003789
日期:——
MASUDA K.; ADACHI J.; SHIBATA T.; NOMURA K., CHEM. AND PHARM. BULL., 1979, 27, NO 7, 1683-1687